Changeflow GovPing Pharma & Drug Safety Methods of preparing a postbiotic composition
Routine Notice Added Final

Methods of preparing a postbiotic composition

Favicon for changeflow.com USPTO Patent Grants - Pharma (A61K)
Published
Detected
Email

Summary

USPTO granted patent US12594308B2 to Science Power SRL covering methods of preparing postbiotic compositions through multiple separate microbial fermentations. The patent, based on Application No. 18909568 filed October 8, 2024, includes 15 claims and lists Federica Nigro as the inventor. The composition may be produced via parallel or sequential fermentation steps.

What changed

USPTO issued Patent No. US12594308B2 granting Science Power SRL exclusive rights to methods of preparing postbiotic compositions using multiple microbial fermentations. The patent covers compositions produced through parallel or sequential fermentation processes, with CPC classifications spanning A61K (medicinal preparations), C12N (microorganisms), and related biotechnology categories.

For competitors in the postbiotic, probiotic, or microbiome therapeutic space, this patent establishes intellectual property barriers around multi-fermentation preparation methods. Companies developing similar composition preparation processes should conduct freedom-to-operate analyses to assess potential infringement risks. The patent holder gains enforceable exclusive rights in the US market for the claimed methods, potentially affecting licensing negotiations and product development strategies in the gut health and microbiome sectors.

What to do next

  1. Monitor for updates

Archived snapshot

Apr 7, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Methods of preparing a postbiotic composition

Grant US12594308B2 Kind: B2 Apr 07, 2026

Assignee

SCIENCE POWER SRL

Inventors

Federica Nigro

Abstract

The disclosure provides methods of preparing a postbiotic composition comprising multiple (i.e., two or more) separate microbial fermentations, which may be performed in parallel or sequential steps.

CPC Classifications

A61K 35/74 A61K 36/064 A61K 47/12 A61P 1/00 C12N 1/18 C12N 1/20 C12N 1/36

Filing Date

2024-10-08

Application No.

18909568

Claims

15

View original document →

Get daily alerts for USPTO Patent Grants - Pharma (A61K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 7th, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12594308B2

Who this affects

Applies to
Pharmaceutical companies Manufacturers
Industry sector
3254.1 Biotechnology
Activity scope
Biologics manufacturing Fermentation processes Composition formulation
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when USPTO Patent Grants - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!